Recently, Baiyunshan Tianxin Company, a subsidiary of Guangzhou Pharmaceutical Group, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, and dexamethasone sodium phosphate injection officially passed the consistent evaluation of generic drug quality and efficacy. This product is mainly suitable for allergic and autoimmune inflammatory diseases. It is used for the comprehensive treatment of certain serious infections, poisoning, and malignant lymphoma. It is a type of national essential drug catalogue and a medicine that is needed for clinical use.

Recently, Baiyunshan Tianxin Company, a subsidiary of Guangzhou Pharmaceutical Group, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, and dexamethasone sodium phosphate injection officially passed the consistent evaluation of generic drug quality and efficacy. This product is mainly suitable for allergic and autoimmune inflammatory diseases. It is used for the comprehensive treatment of certain serious infections, poisoning, and malignant lymphoma. It is a type of national essential drug catalogue and a medicine that is needed for clinical use.